{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:08:52Z","timestamp":1779275332200,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11845-025-04209-7","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:04:51Z","timestamp":1765278291000},"page":"975-983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlations of cerebrospinal fluid neurofilament light chain levels with clinical and electromyography findings in amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3895-0410","authenticated-orcid":false,"given":"Zeliha","family":"Matur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3863-9171","authenticated-orcid":false,"given":"\u015eule","family":"Deveci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u00fcksel","family":"Erdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"4209_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162\u2013172. https:\/\/doi.org\/10.1056\/NEJMra1603471","journal-title":"N Engl J Med"},{"key":"4209_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2 A, Logroscino G, Hardiman O et al (2009) Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler 10:310\u2013323. https:\/\/doi.org\/10.3109\/17482960802566824","journal-title":"Amyotroph Lateral Scler"},{"key":"4209_CR3","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131:1975\u20131978. https:\/\/doi.org\/10.1016\/j.clinph.2020.04.005","journal-title":"Clin Neurophysiol"},{"key":"4209_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(08)70293-X","volume":"8","author":"MR Turner","year":"2009","unstructured":"Turner MR, Kiernan MC, Leigh PN, Talbot K (2009) Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 8:94\u2013109. https:\/\/doi.org\/10.1016\/S1474-4422(08)70293-X","journal-title":"Lancet Neurol"},{"key":"4209_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577\u2013589. https:\/\/doi.org\/10.1038\/s41582-018-0058-z","journal-title":"Nat Rev Neurol"},{"key":"4209_CR6","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen K, De Schaepdryver M, Stubendorff B et al (2017) Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88:2302\u20132309. https:\/\/doi.org\/10.1212\/WNL.0000000000004029","journal-title":"Neurology"},{"key":"4209_CR7","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","volume":"19","author":"R Tortelli","year":"2012","unstructured":"Tortelli R, Ruggieri M, Cortese R et al (2012) Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Eur J Neurol 19:1561\u20131567. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03777.x","journal-title":"Eur J Neurol"},{"key":"4209_CR8","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","volume":"8","author":"J Gaiottino","year":"2013","unstructured":"Gaiottino J, Norgren N, Dobson R et al (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One 8:e75091. https:\/\/doi.org\/10.1371\/journal.pone.0075091","journal-title":"PLoS One"},{"key":"4209_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174152","volume":"20","author":"D Gagliardi","year":"2019","unstructured":"Gagliardi D, Meneri M, Saccomanno D et al (2019) Diagnostic and prognostic role of blood and cerebrospinal fluid and blood neurofilaments in amyotrophic lateral sclerosis: a review of the literature. Int J Mol Sci 20:4152. https:\/\/doi.org\/10.3390\/ijms20174152","journal-title":"Int J Mol Sci"},{"key":"4209_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnagi.2016.00290","volume":"8","author":"D Li","year":"2016","unstructured":"Li D, Shen D, Tai H, Cui L (2016) Neurofilaments in CSF as diagnostic biomarkers in motor neuron disease: a meta-analysis. Front Aging Neurosci 8:290. https:\/\/doi.org\/10.3389\/fnagi.2016.00290","journal-title":"Front Aging Neurosci"},{"key":"4209_CR11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3389\/fneur.2020.00919","volume":"11","author":"Q Sun","year":"2020","unstructured":"Sun Q, Zhao X, Li S et al (2020) CSF neurofilament light chain elevation predicts ALS severity and progression. Front Neurol 11:919. https:\/\/doi.org\/10.3389\/fneur.2020.00919","journal-title":"Front Neurol"},{"key":"4209_CR12","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","volume":"90","author":"E Feneberg","year":"2018","unstructured":"Feneberg E, Oeckl P, Steinacker P et al (2018) Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology 90:e22\u2013e30. https:\/\/doi.org\/10.1212\/WNL.0000000000004761","journal-title":"Neurology"},{"key":"4209_CR13","doi-asserted-by":"publisher","first-page":"22128","DOI":"10.1038\/s41598-021-01499-6","volume":"11","author":"A Behzadi","year":"2021","unstructured":"Behzadi A, Pujol-Calder\u00f3n F, Tjust AE et al (2021) Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics. Sci Rep 11:22128. https:\/\/doi.org\/10.1038\/s41598-021-01499-6","journal-title":"Sci Rep"},{"key":"4209_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia J, Ning Y, Chen M et al (2024) Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N Engl J Med 390:712\u2013722. https:\/\/doi.org\/10.1056\/NEJMoa2310168","journal-title":"N Engl J Med"},{"key":"4209_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U et al (2019) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol 76:791\u2013799. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0765","journal-title":"JAMA Neurol"},{"key":"4209_CR16","doi-asserted-by":"publisher","first-page":"104970","DOI":"10.1016\/j.ebiom.2024.104970","volume":"101","author":"MS Freedman","year":"2024","unstructured":"Freedman MS, Gnanapavan S, Booth RA et al (2024) Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. EBioMedicine 101:104970. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104970","journal-title":"EBioMedicine"},{"key":"4209_CR17","doi-asserted-by":"publisher","first-page":"e200419","DOI":"10.1212\/NXI.0000000000200419","volume":"12","author":"R Klimas","year":"2025","unstructured":"Klimas R, Kohle F, Horstkemper L et al (2025) Serum neurofilament light chain as a biomarker for CIDP diagnosis, severity, and treatment outcome. Neurol Neuroimmunol Neuroinflamm 12:e200419. https:\/\/doi.org\/10.1212\/NXI.0000000000200419","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4209_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ana.25276","volume":"84","author":"M Benatar","year":"2018","unstructured":"Benatar M, Wuu J, Andersen PM et al (2018) Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Ann Neurol 84:130\u2013139. https:\/\/doi.org\/10.1002\/ana.25276","journal-title":"Ann Neurol"},{"key":"4209_CR19","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1038\/s41467-023-42596-6","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai H, Pang Y, Fu X et al (2023) Plasma biomarkers predict Alzheimer\u2019s disease before clinical onset in Chinese cohorts. Nat Commun 14:6747. https:\/\/doi.org\/10.1038\/s41467-023-42596-6","journal-title":"Nat Commun"},{"key":"4209_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117079","volume":"417","author":"V Anderson","year":"2020","unstructured":"Anderson V, Bentley E, Loveless S et al (2020) Serum neurofilament-light concentration and real-world outcome in MS. J Neurol Sci 417:117079. https:\/\/doi.org\/10.1016\/j.jns.2020.117079","journal-title":"J Neurol Sci"},{"key":"4209_CR21","doi-asserted-by":"publisher","first-page":"1354431","DOI":"10.3389\/fneur.2024.1354431","volume":"15","author":"L Sol\u00eds-Tarazona","year":"2024","unstructured":"Sol\u00eds-Tarazona L, Raket LL, Cabello-Murgui J et al (2024) Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis. Front Neurol 15:1354431. https:\/\/doi.org\/10.3389\/fneur.2024.1354431","journal-title":"Front Neurol"},{"key":"4209_CR22","doi-asserted-by":"publisher","first-page":"753242","DOI":"10.3389\/fnagi.2021.753242","volume":"13","author":"V Vacchiano","year":"2021","unstructured":"Vacchiano V, Mastrangelo A, Zenesini C et al (2021) Plasma and CSF neurofilament light chain in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Front Aging Neurosci 13:753242. https:\/\/doi.org\/10.3389\/fnagi.2021.753242","journal-title":"Front Aging Neurosci"},{"key":"4209_CR23","doi-asserted-by":"publisher","first-page":"105323","DOI":"10.1016\/j.ebiom.2024.105323","volume":"108","author":"M Benatar","year":"2024","unstructured":"Benatar M, Macklin EA, Malaspina A et al (2024) Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis. EBioMedicine 108:105323. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105323","journal-title":"EBioMedicine"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04209-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-04209-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04209-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:40:51Z","timestamp":1779273651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-04209-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4209"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-04209-7","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare that no artificial intelligence tools were used in the preparation, writing, or editing of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of Interest"}}]}}